The Medical Device Injection Molding Services segmentation by application delineates five principal sub‑markets that collectively drive the overall market size. Diagnostic devices (approximately 30% of revenue) encompass molded housings for imaging probes, test‑strip cartridges, and point‑of‑care analyzers, where precision tolerances and biocompatibility are critical. Therapeutic devices (about 25%) include components for infusion pumps, dialysis machines, and wearable therapy units, demanding high‑volume production and stringent regulatory compliance. Surgical instruments (20%) cover disposable handles, instrument trays, and robotic‑assisted tool casings, where cost efficiency and rapid turnaround are paramount. Drug delivery systems (15%) involve molded cartridges for insulin pens, inhalers, and implantable reservoirs, requiring tight dimensional control to ensure dose accuracy. Finally, Orthopedic implants (10%) consist of molded polymeric liners and spacers for joint replacement systems, where mechanical strength and long‑term stability dominate design criteria. These application segments together define the market's revenue distribution and guide service providers in tailoring process capabilities to each niche.